Clinical Trials Directory

Trials / Completed

CompletedNCT00889538

Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems

Double-Blind, Placebo-Controlled, Crossover Study of Glutathione, Vitamin C and Cysteine in Children With Autism and Severe Behavior Problems

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
University of Louisville · Academic / Other
Sex
All
Age
5 Years – 16 Years
Healthy volunteers
Not accepted

Summary

This is a double-blind, placebo-controlled crossover study to evaluate the safety and efficacy of glutathione alone or glutathione, vitamin C and NAC treatment in children with autism who also have severe behavior problems. The investigators hypothesis is that children with autism will show improvement in both learning capabilities and behavior with either glutathione, or glutathione, vitamin C and NAC therapy.

Detailed description

This is a prospective, single center, double-blind, randomized pilot study in children and adolescents with autism and severe behavior disorders. All subjects will undergo initial screening procedures to determine eligibility. They will then be randomized to either 8 weeks of placebo or 8 weeks of glutathione or glutathione, vitamin C and N-acetylcysteine. They will receive intravenous treatment weekly and will have ongoing behavioral studies during this period. Following 8 weeks of therapy, they will have a week without treatment then will cross-over to the alternate therapy for weekly intravenous infusions and behavioral testing. In addition to baseline hematology and chemistries, baseline oxidized and reduced glutathione will be measured. These parameters will be repeated at the end of each 8 week course of therapy.

Conditions

Interventions

TypeNameDescription
DRUGplacebo50 mL of 1/2 normal saline IV
DRUGglutathioneglutathione 600 mg IV
DRUGglutathione, vit C and NACGlutathione 600 mg IV Vitamin C 2000 mg IV N-acetylcysteine 20 mg/kg IV (max dose = 600 mg) Mix above three in 1/2 NS for a total volume of 50 mL

Timeline

Start date
2009-04-01
Primary completion
2012-09-01
Completion
2012-09-01
First posted
2009-04-29
Last updated
2016-12-07

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT00889538. Inclusion in this directory is not an endorsement.